A subset of our organoid data sets come from studies that performed diverse perturbations (22q11.2 deletion, SMARCB1 knockdown, exposure to Alzheimer’s serum, amyotrophic lateral sclerosis patient-derived organoids). This evidence concerns the gene SMARCB1 and amyotrophic lateral sclerosis.